FDA Drug Recalls

Recalls / Class III

Class IIID-0070-2023

Product

Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

Brand name
Phenytoin Sodium
Generic name
Phenytoin Sodium
Active ingredient
Phenytoin Sodium
Route
Intramuscular, Intravenous
NDC
42192-614
FDA application
ANDA040573
Affected lot / code info
Lot: E026A001 Exp. 06/2023

Why it was recalled

Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Recalling firm

Firm
Acella Pharmaceuticals, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1880 Mcfarland Pkwy Ste 110, N/A, Alpharetta, Georgia 30005-1795

Distribution

Quantity
637 cartons
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2022-11-14
FDA classified
2022-11-23
Posted by FDA
2022-11-30
Terminated
2024-08-21
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0070-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Phenytoin Sodium · FDA Drug Recalls